Found: 6
Select item for more details and to access through your institution.
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01046-5
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907
- By:
- Publication type:
- Article
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37736-3
- By:
- Publication type:
- Article
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 1, p. 327, doi. 10.1007/s12253-018-0473-x
- By:
- Publication type:
- Article
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1509, doi. 10.21873/invivo.13599
- By:
- Publication type:
- Article
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2741
- By:
- Publication type:
- Article